Six months into the 117th Congress, the U.S. Senate has recently increased its oversight activities following a slow start. Since April, newly empowered Democratic Members have launched or requested more than 20 inquiries...more
7/6/2021
/ Anti-Competitive ,
Biden Administration ,
Congressional Oversight ,
Coronavirus/COVID-19 ,
Cryptocurrency ,
Cybersecurity ,
Diversity and Inclusion Standards (D&I) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Manufacturers ,
Pharmaceutical Industry ,
Popular ,
Relief Measures
With the majority in both the U.S. House and Senate, Democrats are poised to chair powerful investigative committees in the 117th Congress -
With the victories of Raphael Warnock over incumbent Kelly Loeffler, and Jon...more
1/11/2021
/ Anti-Competitive ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
Diversity ,
Energy Sector ,
Environmental Policies ,
Environmental Social & Governance (ESG) ,
Financial Services Industry ,
Georgia ,
Healthcare Reform ,
Regulatory Oversight ,
Regulatory Oversight Committee ,
Relief Measures ,
Social Media ,
Technology Sector